TrialLeukemia2026

ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study.

Mouhamad Khouja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.